News
ZLDAF
0.0089
NaN%
--
Weekly Report: what happened at ZLDAF last week (1109-1113)?
Weekly Report · 2d ago
Weekly Report: what happened at ZLDAF last week (1102-1106)?
Weekly Report · 11/09 09:48
Weekly Report: what happened at ZLDAF last week (1026-1030)?
Weekly Report · 11/02 09:47
Zelira Clinches US$33m HOPE® 1 Funding Deal to Advance FDA Pathway
TipRanks · 10/30 01:37
Weekly Report: what happened at ZLDAF last week (1019-1023)?
Weekly Report · 10/26 09:47
Weekly Report: what happened at ZLDAF last week (1012-1016)?
Weekly Report · 10/19 09:47
Weekly Report: what happened at ZLDAF last week (1005-1009)?
Weekly Report · 10/12 09:50
Weekly Report: what happened at ZLDAF last week (0928-1002)?
Weekly Report · 10/05 09:50
Weekly Report: what happened at ZLDAF last week (0921-0925)?
Weekly Report · 09/28 09:47
Weekly Report: what happened at ZLDAF last week (0914-0918)?
Weekly Report · 09/21 09:47
Weekly Report: what happened at ZLDAF last week (0907-0911)?
Weekly Report · 09/14 09:50
Weekly Report: what happened at ZLDAF last week (0831-0904)?
Weekly Report · 09/07 09:46
Weekly Report: what happened at ZLDAF last week (0824-0828)?
Weekly Report · 08/31 09:51
Weekly Report: what happened at ZLDAF last week (0817-0821)?
Weekly Report · 08/24 09:51
ASX Flags Possible Delisting of Zelira Therapeutics Over Unpaid Listing Fees
TipRanks · 08/24 01:08
Weekly Report: what happened at ZLDAF last week (0810-0814)?
Weekly Report · 08/17 09:52
Weekly Report: what happened at ZLDAF last week (0803-0807)?
Weekly Report · 08/10 09:49
Weekly Report: what happened at ZLDAF last week (0727-0731)?
Weekly Report · 08/03 09:48
Zelira Secures US$33m for HOPE® 1 SPV to Advance FDA Autism Trial
TipRanks · 07/30 01:17
Weekly Report: what happened at ZLDAF last week (0720-0724)?
Weekly Report · 07/27 09:51
More
Webull provides a variety of real-time ZLDAF stock news. You can receive the latest news about Zelira Therapeutics Limited through multiple platforms. This information may help you make smarter investment decisions.
About ZLDAF
Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company is engaged in the research, development and commercialization of clinically validated cannabinoid-based medicines. It owns a portfolio of products and a pipeline of candidates undergoing clinical development to enter global markets. It is focused on developing and clinically validating cannabinoid-based medicines in its prescription (Rx) business for the treatment of a variety of medical conditions, including insomnia, autism and chronic non-cancer pain, as well as offering over the counter (OTC) products. It has two medications: HOPE and ZENIVOL. ZENIVOL is a cannabinoid-based medicine for the treatment of chronic insomnia. The Company is in partnership with SprinJeneCBD, introduced a full line of oral care products. Its RAFFIVE brand, which consists of five over-the-counter acne treatment products using a proprietary formulation incorporating cannabidiol (CBD).